Congress:
ECR25
Poster Number:
C-23987
Type:
Poster: EPOS Radiologist (educational)
Authorblock:
M. Begerano Fayos, M. D. Sánchez Valverde, L. Perez Rodriguez; San Juan de Alicante/ES
Disclosures:
María Begerano Fayos:
Nothing to disclose
María Dolores Sánchez Valverde:
Nothing to disclose
Lourdes Perez Rodriguez:
Nothing to disclose
Keywords:
Lung, CT, Chemotherapy, Education, Drugs / Reactions, Toxicity
- Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, et al. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment. Vol. 7, ESMO Open. Elsevier B.V.; 2022.
- Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, et al. Drug-induced interstitial lung disease: A systematic review. Vol. 7, Journal of Clinical Medicine. MDPI; 2018.
- Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V. Drug-induced interstitial lung disease. Vol. 60, European Respiratory Journal. European Respiratory Society; 2022.
- Bridi G das P, Fonseca EKUN, Kairalla RA, Amaral AF, Baldi BG. Drug-induced lung disease: a narrative review. Vol. 50, Jornal brasileiro de pneumologia: publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2024. p. e20240110.
- Ufuk F, BayraktaroÄŸlu S, Ütebey AR. Drug-induced lung disease: a brief update for radiologists. Diagnostic and Interventional Radiology. 2023;29(1):80–90.